TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Hans Lennernäs Biomedical AB
Closing information (x1000 DKK)
| Closing information | 2023/06 | 2022/06 | 2021/06 |
| Turnover |
798
|
543
|
355 |
| Financial expenses |
280
|
297
|
3 |
| Earnings before taxes |
62
|
48
|
-66 |
| EBITDA |
342
|
337
|
-81 |
| Total assets |
9,503
|
10,549
|
11,217 |
| Current assets |
734
|
651
|
513 |
| Current liabilities |
246
|
189
|
121 |
| Equity capital |
9,187
|
10,277
|
10,997 |
| - share capital |
63
|
70
|
73 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Solvency |
96.7%
|
97.4%
|
98.0% |
| Turnover per employee |
798
|
543
|
355 |
| Profit as a percentage of turnover |
7.8%
|
8.8%
|
-18.6% |
| Return on assets (ROA) |
3.6%
|
3.3%
|
-0.6% |
| Current ratio |
298.4%
|
344.4%
|
424.0% |
| Return on equity (ROE) |
0.7%
|
0.5%
|
-0.6% |
| Change turnover |
306
|
207
|
-88 |
| Change turnover % |
62%
|
61%
|
-20% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.